Table 6.
Predictors | aCrude HR (95% CI) | bAdjusted HR (95% CI) |
---|---|---|
Sex | ||
Female | 1.00 | 1.00 |
Male | 1.27 (1.02–1.60) | 1.68 (1.19–2.37) |
Preoperative carcino-embryonic antigen (CEA) level | ||
Not elevated | 1.00 | 1.00 |
Elevated | 2.03 (1.55–2.65) | 2.09 (1.39–2.37) |
Duke’s stages | ||
A&B | 1.00 | 1.00 |
C | 1.27 (0.89–1.80) | 1.16 (0.79–1.72) |
D | 3.98 (2.37–5.80) | 3.97 (2.59–6.10) |
Tumour grades | ||
Low | 1.00 | 1.00 |
High | 2.99 (1.92–4.67) | 2.91 (1.65–5.14) |
HR hazard ratio, CI confidence interval
aUnivariate Cox Proportional Hazard Regression analysis
bMultivariate Cox Proportional Hazard Regression analysis, adjusted for age, gender, co- morbidities (diabetes mellitus, hypertension), tumour grade and treatment modalities